| Year |
Citation |
Score |
| 2022 |
Sheng S, Bernardo M, Dzinic SH, Chen K, Sakr WA. The vulnerable primed cancer stem cells in disguise: demystifying the role of Maspin. Cancer Metastasis Reviews. 1-10. PMID 36451067 DOI: 10.1007/s10555-022-10070-2 |
0.394 |
|
| 2019 |
Dzinic SH, Mahdi Z, Bernardo MM, Vranic S, Beydoun H, Nahra N, Alijagic A, Harajli D, Pang A, Saliganan DM, Rahman AM, Skenderi F, Hasanbegovic B, Dyson G, Beydoun R, ... Sheng S, et al. Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma. Plos One. 14: e0215089. PMID 31002675 DOI: 10.1371/Journal.Pone.0215089 |
0.317 |
|
| 2018 |
Sheng S, Margarida Bernardo M, Dzinic SH, Chen K, Heath EI, Sakr WA. Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review. Cancer Metastasis Reviews. PMID 30484007 DOI: 10.1007/S10555-018-9767-4 |
0.505 |
|
| 2017 |
Kidder BL, He R, Wangsa D, Padilla-Nash HM, Bernardo MM, Sheng S, Ried T, Zhao K. SMYD5 controls heterochromatin and chromosome integrity during embryonic stem cell differentiation. Cancer Research. PMID 28951459 DOI: 10.1158/0008-5472.Can-17-0828 |
0.438 |
|
| 2017 |
Zhang M, Hendrix MJC, Pemberton PA, Sakr WA, Sheng S. An Essential Role of Maspin in Embryogenesis and Tumor Suppression-Response. Cancer Research. PMID 28877938 DOI: 10.1158/0008-5472.Can-17-1254 |
0.466 |
|
| 2017 |
Bernardo MM, Dzinic SH, Matta MJ, Dean I, Saker L, Sheng S. The Opportunity of Precision Medicine for Breast Cancer with Context-Sensitive Tumor Suppressor Maspin. Journal of Cellular Biochemistry. PMID 28262971 DOI: 10.1002/Jcb.25969 |
0.803 |
|
| 2016 |
Dean I, Dzinic SH, Bernardo MM, Zou Y, Kimler V, Li X, Kaplun A, Granneman J, Mao G, Sheng S. The secretion and biological function of tumor suppressor maspin as an exosome cargo protein. Oncotarget. PMID 28009978 DOI: 10.18632/Oncotarget.13302 |
0.806 |
|
| 2016 |
Dzinic SH, Bernardo MM, Li X, Fernandez-Valdivia R, Ho YS, Mi QS, Bandyopadhyay S, Lonardo F, Vranic S, Oliveira D, Bonfil RD, Dyson G, Chen K, Omerovic A, Sheng X, ... ... Sheng S, et al. An essential role of maspin in embryogenesis and tumor suppression. Cancer Research. PMID 27923833 DOI: 10.1158/0008-5472.Can-16-2219 |
0.541 |
|
| 2016 |
Huang B, Yin M, Li X, Cao G, Qi J, Lou G, Sheng S, Kou J, Chen K, Yu B. Migration-Inducing Gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer. Oncotarget. PMID 27050277 DOI: 10.18632/Oncotarget.8487 |
0.458 |
|
| 2016 |
Oliveira DS, Dzinic S, Bonfil AI, Saliganan AD, Sheng S, Bonfil RD. The mouse prostate: a basic anatomical and histological guideline. Bosnian Journal of Basic Medical Sciences / Udruzenje Basicnih Mediciniskih Znanosti = Association of Basic Medical Sciences. PMID 26773172 DOI: 10.17305/Bjbms.2016.917 |
0.346 |
|
| 2015 |
Dzinic SH, Bernardo MM, Oliveira DS, Wahba M, Sakr W, Sheng S. Tumor suppressor maspin as a modulator of host immune response to cancer. Bosnian Journal of Basic Medical Sciences / UdružEnje BasičNih Mediciniskih Znanosti = Association of Basic Medical Sciences. 15: 1-6. PMID 26614844 DOI: 10.17305/Bjbms.2015.783 |
0.596 |
|
| 2015 |
Thakur MK, Heilbrun LK, Sheng S, Stein M, Liu G, Antonarakis ES, Vaishampayan U, Dzinic SH, Li X, Freeman S, Smith D, Heath EI. A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study. Investigational New Drugs. PMID 26581400 DOI: 10.1007/S10637-015-0307-6 |
0.393 |
|
| 2015 |
Bernardo MM, Kaplun A, Dzinic SH, Li X, Irish J, Mujagic A, Jakupovic B, Back JB, Van Buren E, Han X, Dean I, Chen YQ, Heath E, Sakr W, Sheng S. Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug Sensitivity. Cancer Research. PMID 26208903 DOI: 10.1158/0008-5472.Can-15-0234 |
0.812 |
|
| 2014 |
Dzinic SH, Chen K, Thakur A, Kaplun A, Bonfil RD, Li X, Liu J, Bernardo MM, Saliganan A, Back JB, Yano H, Schalk DL, Tomaszewski EN, Beydoun AS, Dyson G, ... ... Sheng S, et al. Maspin expression in prostate tumor elicits host anti-tumor immunity. Oncotarget. 5: 11225-36. PMID 25373490 DOI: 10.18632/Oncotarget.2615 |
0.821 |
|
| 2013 |
Dzinic SH, Kaplun A, Li X, Bernardo M, Meng Y, Dean I, Krass D, Stemmer P, Shin N, Lonardo F, Sheng S. Identification of an intrinsic determinant critical for maspin subcellular localization and function. Plos One. 8: e74502. PMID 24278104 DOI: 10.1371/Journal.Pone.0074502 |
0.798 |
|
| 2013 |
Wang Y, Sheng S, Zhang J, Dzinic S, Li S, Fang F, Wu N, Zheng Q, Yang Y. Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC). Plos One. 8: e63581. PMID 23717449 DOI: 10.1371/Journal.Pone.0063581 |
0.534 |
|
| 2013 |
Heath EI, Stein MN, Vaishampayan UN, Antonarakis ES, Liu G, Sheng S, Farrow K, Smith DW, Heilbrun LK. Phase II trial of single-agent ganetespib (STA-9090), a heat shock protein 90 (Hsp90) inhibitor in heavily pretreated patients with metastatic castration-resistant prostate cancer (mCRPC) post docetaxel-based chemotherapy: Results of a Prostate Cancer Clinical Trials Consortium (PCCTC) study. Journal of Clinical Oncology. 31: 5085-5085. DOI: 10.1200/Jco.2013.31.15_Suppl.5085 |
0.358 |
|
| 2013 |
Dzinic SH, Kaplun A, Li X, Bernardo MM, Dean I, Lonardo F, Sheng S. Abstract 5203: Identification of an intrinsic determinant critical for maspin subcellular localization and function. Cancer Research. 73: 5203-5203. DOI: 10.1158/1538-7445.Am2013-5203 |
0.803 |
|
| 2013 |
Dean IS, Dzinic S, Kaplun A, Zou Y, Mao G, Sheng S. Abstract 5067: Human prostate epithelial cells secrete the tumor suppressor maspin as a soluble and exosome-associated protein . Cancer Research. 73: 5067-5067. DOI: 10.1158/1538-7445.Am2013-5067 |
0.63 |
|
| 2013 |
Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, Reddy GPV, Sarkar FH. Regulation of FOXO3a/β-catenin/GSK-3β signaling by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. Journal of Biological Chemistry. 288: 34755-34755. DOI: 10.1074/Jbc.A113.701978 |
0.399 |
|
| 2013 |
Kaplun A, Bernardo MM, Dzinic S, Li X, Dean I, Jakupovic B, Liu J, Heath E, Sakr W, Sheng S. Towards curative cancer therapy with maspin: A unique window of opportunity to target cancer dormancy Epigenetics and Cancer. 273-280. DOI: 10.1007/978-94-007-6612-9_15 |
0.724 |
|
| 2012 |
Kaplun A, Dzinic S, Bernardo M, Sheng S. Tumor suppressor maspin as a rheostat in HDAC regulation to achieve the fine-tuning of epithelial homeostasis. Critical Reviews in Eukaryotic Gene Expression. 22: 249-58. PMID 23140166 DOI: 10.1615/Critreveukargeneexpr.V22.I3.80 |
0.513 |
|
| 2011 |
Bernardo MM, Meng Y, Lockett J, Dyson G, Dombkowski A, Kaplun A, Li X, Yin S, Dzinic S, Olive M, Dean I, Krass D, Moin K, Bonfil RD, Cher M, ... ... Sheng S, et al. Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation. Genes & Cancer. 2: 1009-22. PMID 22737267 DOI: 10.1177/1947601912440170 |
0.792 |
|
| 2011 |
Li X, Kaplun A, Lonardo F, Heath E, Sarkar FH, Irish J, Sakr W, Sheng S. HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells. Molecular Cancer Research : McR. 9: 733-45. PMID 21622623 DOI: 10.1158/1541-7786.Mcr-10-0505 |
0.492 |
|
| 2011 |
Dean I, Bernardo M, Li X, Dzinic S, Yin S, Moin K, Sakr W, Sheng S. Abstract 3359: Maspin induces MET in prostate cancer cells cultured in 3D-collagen I Cancer Research. 71: 3359-3359. DOI: 10.1158/1538-7445.Am2011-3359 |
0.817 |
|
| 2010 |
Cai J, Kandagatla P, Singareddy R, Kropinski A, Sheng S, Cher ML, Chinni SR. Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells. Translational Oncology. 3: 195-203. PMID 20563261 DOI: 10.1593/Tlo.09328 |
0.535 |
|
| 2010 |
Lonardo F, Li X, Kaplun A, Soubani A, Sethi S, Gadgeel S, Sheng S. The natural tumor suppressor protein maspin and potential application in non small cell lung cancer. Current Pharmaceutical Design. 16: 1877-81. PMID 20337574 DOI: 10.2174/138161210791208974 |
0.486 |
|
| 2010 |
Li X, Heath E, Sakr WA, Sheng S. Abstract 5000: Epigenetic de-silencing of Glutathione s-transferase pi by tumor suppressive maspin Cellular and Molecular Biology. 70: 5000-5000. DOI: 10.1158/1538-7445.Am10-5000 |
0.467 |
|
| 2010 |
Dzinic S, Meng Y, Sheng S. Abstract 2352: Critical structural determinants of maspin necessary for maspin's subcellular localization, biological, and biochemical functions Cancer Research. 70: 2352-2352. DOI: 10.1158/1538-7445.Am10-2352 |
0.548 |
|
| 2009 |
Sheng S, Qiao M, Pardee AB. Metastasis and AKT activation. Journal of Cellular Physiology. 218: 451-4. PMID 18988188 DOI: 10.1002/Jcp.21616 |
0.56 |
|
| 2008 |
Heath EI, Hillman DW, Vaishampayan U, Sheng S, Sarkar F, Harper F, Gaskins M, Pitot HC, Tan W, Ivy SP, Pili R, Carducci MA, Erlichman C, Liu G. A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7940-6. PMID 19047126 DOI: 10.1158/1078-0432.Ccr-08-0221 |
0.387 |
|
| 2008 |
Qiao M, Sheng S, Pardee AB. Metastasis and AKT activation. Cell Cycle (Georgetown, Tex.). 7: 2991-6. PMID 18818526 DOI: 10.4161/Cc.7.19.6784 |
0.418 |
|
| 2008 |
Yang H, Murthy S, Sarkar FH, Sheng S, Reddy GP, Dou QP. Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells. Journal of Cellular Physiology. 217: 569-76. PMID 18726991 DOI: 10.1002/Jcp.21565 |
0.469 |
|
| 2008 |
Dong Z, Saliganan AD, Meng H, Nabha SM, Sabbota AL, Sheng S, Bonfil RD, Cher ML. Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover. Neoplasia (New York, N.Y.). 10: 439-49. PMID 18472961 DOI: 10.1593/Neo.08106 |
0.573 |
|
| 2008 |
Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Research. 18: 350-9. PMID 18270520 DOI: 10.1038/Cr.2008.24 |
0.346 |
|
| 2007 |
Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, Reddy GP, Sarkar FH. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. The Journal of Biological Chemistry. 282: 21542-50. PMID 17522055 DOI: 10.1074/Jbc.M701978200 |
0.401 |
|
| 2007 |
Li X, Chen D, Yin S, Meng Y, Yang H, Landis-Piwowar KR, Li Y, Sarkar FH, Reddy GP, Dou QP, Sheng S. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells. Journal of Cellular Physiology. 212: 298-306. PMID 17458898 DOI: 10.1002/Jcp.21102 |
0.5 |
|
| 2007 |
Chen D, Cui QC, Yang H, Barrea RA, Sarkar FH, Sheng S, Yan B, Reddy GP, Dou QP. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Cancer Research. 67: 1636-44. PMID 17308104 DOI: 10.1158/0008-5472.Can-06-3546 |
0.568 |
|
| 2007 |
Heath EI, Hillman D, Vaishampayan U, Sheng S, Sarkar FH, Gaskins M, Pitot HC, Tan W, Ivy P, Pili R. A phase II trial of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in patients with hormone-refractory metastatic prostate cancer Journal of Clinical Oncology. 25: 15553-15553. DOI: 10.1200/Jco.2007.25.18_Suppl.15553 |
0.345 |
|
| 2006 |
De Clerck YA, Weissman BE, Yu D, Parsons R, Bar-Eli M, Roy-Burman P, Seewaldt VL, Cress AE, Languino LR, Batra SK, Tang CK, Sheng S, Chen WT, Chellappan S, Cheng SY, et al. Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC. Cancer Biology & Therapy. 5: 1588-99. PMID 17224636 DOI: 10.4161/Cbt.5.12.3660 |
0.362 |
|
| 2006 |
Sheng S. A role of novel serpin maspin in tumor progression: The divergence revealed through efforts to converge Journal of Cellular Physiology. 209: 631-635. PMID 17001674 DOI: 10.1002/Jcp.20786 |
0.546 |
|
| 2006 |
Li X, Yin S, Meng Y, Sakr W, Sheng S. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Research. 66: 9323-9. PMID 16982778 DOI: 10.1158/0008-5472.Can-06-1578 |
0.52 |
|
| 2006 |
Reddy GP, Barrack ER, Dou QP, Menon M, Pelley R, Sarkar FH, Sheng S. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer. Journal of Cellular Biochemistry. 98: 1408-23. PMID 16619263 DOI: 10.1002/Jcb.20927 |
0.441 |
|
| 2006 |
Yin S, Lockett J, Meng Y, Biliran H, Blouse GE, Li X, Reddy N, Zhao Z, Lin X, Anagli J, Cher ML, Sheng S. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Research. 66: 4173-81. PMID 16618739 DOI: 10.1158/0008-5472.Can-05-3514 |
0.77 |
|
| 2006 |
Lockett J, Yin S, Li X, Meng Y, Sheng S. Tumor suppressive maspin and epithelial homeostasis. Journal of Cellular Biochemistry. 97: 651-60. PMID 16329135 DOI: 10.1002/Jcb.20721 |
0.815 |
|
| 2006 |
Lonardo F, Li X, Siddiq F, Singh R, Al-Abbadi M, Pass HI, Sheng S. Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma. Lung Cancer (Amsterdam, Netherlands). 51: 31-9. PMID 16159682 DOI: 10.1016/j.lungcan.2005.07.011 |
0.324 |
|
| 2005 |
Heath EI, Gaskins M, Pitot HC, Pili R, Tan W, Marschke R, Liu G, Hillman D, Sarkar F, Sheng S, Erlichman C, Ivy P. A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer. Clinical Prostate Cancer. 4: 138-41. PMID 16197617 DOI: 10.3816/Cgc.2005.N.024 |
0.35 |
|
| 2005 |
Yin S, Li X, Meng Y, Finley RL, Sakr W, Yang H, Reddy N, Sheng S. Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. The Journal of Biological Chemistry. 280: 34985-96. PMID 16049007 DOI: 10.1016/S0022-5347(05)00627-0 |
0.547 |
|
| 2005 |
Ketcham CM, Anai S, Reutzel R, Sheng S, Schuster SM, Brenes RB, Agbandje-McKenna M, McKenna R, Rosser CJ, Boehlein SK. p37 Induces tumor invasiveness. Molecular Cancer Therapeutics. 4: 1031-8. PMID 16020660 DOI: 10.1158/1535-7163.Mct-05-0040 |
0.384 |
|
| 2005 |
Tahmatzopoulos A, Sheng S, Kyprianou N. Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis. Oncogene. 24: 5375-83. PMID 16007219 DOI: 10.1038/Sj.Onc.1208684 |
0.56 |
|
| 2005 |
Dong Z, Bonfil RD, Chinni S, Deng X, Trindade Filho JC, Bernardo M, Vaishampayan U, Che M, Sloane BF, Sheng S, Fridman R, Cher ML. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. The American Journal of Pathology. 166: 1173-86. PMID 15793297 DOI: 10.1016/S0002-9440(10)62337-1 |
0.413 |
|
| 2004 |
Sheng S. The promise and challenge toward the clinical application of maspin in cancer Frontiers in Bioscience : a Journal and Virtual Library. 9: 2733-2745. PMID 15353310 |
0.471 |
|
| 2004 |
Liu J, Yin S, Reddy N, Spencer C, Sheng S. Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Research. 64: 1703-11. PMID 14996730 DOI: 10.1158/0008-5472.Can-03-2568 |
0.55 |
|
| 2003 |
Cher ML, Biliran HR, Bhagat S, Meng Y, Che M, Lockett J, Abrams J, Fridman R, Zachareas M, Sheng S. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proceedings of the National Academy of Sciences of the United States of America. 100: 7847-52. PMID 12788977 DOI: 10.1073/Pnas.1331360100 |
0.791 |
|
| 2002 |
Pierson CR, McGowen R, Grignon D, Sakr W, Dey J, Sheng S. Maspin is up-regulated in premalignant prostate epithelia. The Prostate. 53: 255-62. PMID 12430137 DOI: 10.1002/Pros.10107 |
0.509 |
|
| 2002 |
Jiang N, Meng Y, Zhang S, Mensah-Osman E, Sheng S. Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene. 21: 4089-98. PMID 12037665 DOI: 10.1038/Sj.Onc.1205507 |
0.476 |
|
| 2001 |
Sheng S. The urokinase-type plasminogen activator system in prostate cancer metastasis Cancer and Metastasis Reviews. 20: 287-296. PMID 12085967 DOI: 10.1023/A:1015539612576 |
0.354 |
|
| 2001 |
Reddy KB, McGowen R, Schuger L, Visscher D, Sheng S. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model. Oncogene. 20: 6538-43. PMID 11641778 DOI: 10.1038/Sj.Onc.1204796 |
0.448 |
|
| 1998 |
Biswas DK, Averboukh L, Sheng S, Martin K, Ewaniuk DS, Jawde TF, Wang F, Pardee AB. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor. Molecular Medicine (Cambridge, Mass.). 4: 454-67. PMID 9713824 DOI: 10.1007/Bf03401751 |
0.347 |
|
| 1998 |
Zhang M, Martin KJ, Sheng S, Sager R. Expression genetics: a different approach to cancer diagnosis and prognosis. Trends in Biotechnology. 16: 66-71. PMID 9487733 DOI: 10.1016/S0167-7799(97)01157-8 |
0.401 |
|
| 1998 |
Sheng S, Truong B, Fredrickson D, Wu R, Pardee AB, Sager R. Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proceedings of the National Academy of Sciences of the United States of America. 95: 499-504. PMID 9435220 DOI: 10.1073/Pnas.95.2.499 |
0.524 |
|
| 1997 |
Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM, Shi YE. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4 Oncogene. 14: 2767-2774. PMID 9190892 DOI: 10.1038/Sj.Onc.1201245 |
0.51 |
|
| 1997 |
Zhang M, Sheng S, Maass N, Sager R. mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility. Molecular Medicine (Cambridge, Mass.). 3: 49-59. PMID 9132279 DOI: 10.1007/Bf03401667 |
0.519 |
|
| 1996 |
Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, Sager R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 93: 11669-74. PMID 8876194 DOI: 10.1073/Pnas.93.21.11669 |
0.554 |
|
| 1996 |
Sager R, Sheng S, Pemberton P, Hendrix MJ. Maspin: a tumor suppressing serpin. Current Topics in Microbiology and Immunology. 213: 51-64. PMID 8814994 DOI: 10.1007/978-3-642-61107-0_4 |
0.586 |
|
| 1994 |
Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (New York, N.Y.). 263: 526-9. PMID 8290962 DOI: 10.1126/Science.8290962 |
0.588 |
|
| Show low-probability matches. |